Sentence examples for mortality reduction predicted from inspiring English sources

The explanation for this lower than expected mortality reduction, predicted by MISCAN, is as follows.

They argued that the estimated mortality reduction from screening may be lower than the mortality reduction predicted by MISCAN (van den Akker-van Marle et al, 1999) because of the lower sensitivity of the UK screening programme in the early years of screening.

Thus, the mortality reductions predicted here may underestimate the true reduction.

The study was powered to detect a mortality reduction in predicted nonsurvivors from 90%% to 45 % with esmolol, with a power of 0.80 and type-1 error of 0.05.

While the predicted mortality reduction and life years gained attributed to screening did not vary much across risk factor assumptions, there were small differences in the predicted increase in life years gained resulting from a shift to screening initiation at age 45 rather than a later initiation at age 50 years.

With the 36% improvement in surfactant use seen, to reliably detect the predicted mortality reduction, we would require a trial of collaboratives about nine times larger (9×1500), that is at least 13 500 infants individually randomised.

To analyze the potential magnitude of this underestimation, we recomputed the static (HEAT) model predicted mortality reduction using a continuous dose-response function combined with categorical prevalence data using smaller bins (i.e., divided into eleven categories of weekly time spent walking for transportation).

There were small differences in the predicted CRC mortality reduction (Table 3) and life years gained (Table 4) across risk factor mechanisms.

Also for public health modeling, Mulder et al. [ 16] applied changes in smoking status to predict future mortality reduction through smoking cessation.

We compared cancer prognosis between women invited for screening and those not yet invited in East Anglia, UK, in order to predict the mortality reduction achievable by screening, independently of any reduction due to changes in treatment and underlying disease.

The predicted breast cancer mortality reduction due to screening ranged from 15.9%to36.7%7% of all breast cancer deaths from age 40 to 85 years for different scenarios (Table 2).